medicine

Researchers will focus on an immunotherapy known as CAR T, which uses genetically modified stem cells to target and destroy the virus.

A unique approach developed at UCLA suggests a possible path toward treatments for other types of severe infection.

Having witnessed the struggles of her own family and others, Melissa Rios learned early on how education, poverty and health are linked.

Research brief: Findings from a UCLA study indicate some men may not require the intensive treatment they have traditionally received.

The award from the National Cancer Institute will fund a series of collaborative research projects over five years at UCLA.

The immunotherapy drug combination is currently being reviewed for approval under a new FDA pilot program.

By repurposing drugs originally intended for other uses, scientists are pushing forward the fight against cancer.

In lab tests, remdesivir appears to work against the SARS-CoV-2 virus that causes COVID-19.

Research brief: When tested in mice with melanoma tumors that were unlikely to stimulate an immune response, the approach increased the number of anti-tumor immune cells.

Report from Web of Science Group identifies researchers in 21 fields whose work was most often referenced by other papers.

The study highlights the need to teach consumers about the dangers of some drug interactions.

A separate grant of $3.3 million will fund a study on the effectiveness of text messages for helping people adhere to their treatment regimens.

Melioidosis claims an estimated 90,000 lives worldwide each year, but there is no vaccine, and the bacterium that causes it can usually resist even the strongest antibiotics.

Of mice that received high doses of radiation, nearly all that received a compound developed by UCLA scientists survived.

“We can no longer look at this disease as one in which we should always be measuring survival in months,” said UCLA’s Dr. Edward Garon, the lead author.

UCLA research contributes to assessing the reliability of industry-funded drug trials.

Class of 2019 medical students across the country learned which hospital has accepted them for residency, or advanced training in their chosen specialty.

A preview of the paper that was posted on the website ChemRxiv was downloaded 19,000 times in 24 hours, shattering the site’s previous record of 15,000 downloads in six months.

The study suggests that using pembrolizumab and SD-101 together could be effective for people whose tumors have not responded to other therapies.

A UCLA neurologist offers 7 tips for those of us who spend too much time awake.

Chemical engineer Yunfeng Lu has helped develop a way to deliver natural enzymes to the liver, speeding up the metabolism of alcohol.

Housed inside the California NanoSystems Institute, Magnify helps startups succeed by providing access to equipment and entrepreneurial networking.

Class of 2018 medical students across the country learned which hospital has accepted them for residency, or advanced training in their chosen specialty.

UCLA chemistry professor helped develop Erleada, which was recently approved by the FDA for treating an especially lethal form of prostate cancer.

“This technology is a game-changer for us drug discovery scientists,” said Robert Damoiseaux, a UCLA professor of molecular and medical pharmacology.